Healthcare -
Biotechnology - NASDAQ - US
$ 3.76
-0.529 %
$ 336 M
Market Cap
-8.55
P/E
TRVI - CASH & EQUIVALENTS
Cash & Equivalents TRVI - Trevi Therapeutics, Inc.
32.4 M
LAST VALUE
-6.21%
2 YEAR CAGR
13.55%
5 YEAR CAGR
0.00%
10 YEAR CAGR